A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin

BACKGROUND: Dipeptidyl peptidase-4 (DPP-4) inhibitors and sodium–glucose co-transporter 2 (SGLT2) inhibitors improve hyperglycemia, and the usefulness of co-administration of DPP-4 inhibitors and insulin therapy has been well established. However, it has been still uncertain whether combination ther...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetol Metab Syndr
Main Authors: Nomoto, Hiroshi, Miyoshi, Hideaki, Sugawara, Hajime, Ono, Kota, Yanagiya, Shingo, Oita, Mayuko, Nakamura, Akinobu, Atsumi, Tatsuya
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5514514/
https://ncbi.nlm.nih.gov/pubmed/28725273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-017-0255-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados